Heron Therapeutics (HRTX) Scheduled to Post Quarterly Earnings on Tuesday

Heron Therapeutics (NASDAQ:HRTX - Get Free Report) is scheduled to release its earnings data before the market opens on Tuesday, November 12th. Analysts expect Heron Therapeutics to post earnings of ($0.03) per share for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.

Heron Therapeutics (NASDAQ:HRTX - Get Free Report) last released its earnings results on Tuesday, August 6th. The biotechnology company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The company had revenue of $36.02 million during the quarter, compared to analyst estimates of $35.35 million. During the same period in the prior year, the company earned ($0.35) earnings per share.

Heron Therapeutics Trading Down 0.6 %

NASDAQ HRTX traded down $0.01 during trading hours on Tuesday, hitting $1.77. 958,214 shares of the company's stock were exchanged, compared to its average volume of 2,399,217. The stock has a 50-day simple moving average of $1.88 and a 200 day simple moving average of $2.58. Heron Therapeutics has a 1-year low of $0.50 and a 1-year high of $3.93. The firm has a market cap of $268.46 million, a price-to-earnings ratio of -5.34 and a beta of 1.81.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reissued a "buy" rating and issued a $5.00 price objective on shares of Heron Therapeutics in a research note on Wednesday, September 25th.

About Heron Therapeutics

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.